Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - carl+davis
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
SARS-CoV-2 Neutralizing Human Monoclonal Antibodies
Application Monoclonal antibodies to SARS-CoV2 for use in COVID-19 diagnostics and therapeutics. Key Benefits Demonstrably neutralizing, important for therapeutic mAbs. Most bind both RBG and stalk portion of spike protein, useful in case SARS-CoV2 strains develop variation in RBD. Market Summary Coronavirus (COVID-19) is an infectious...
Published: 7/30/2024
|
Inventor(s):
Jens Wrammert
,
Carl Davis
,
Mehul Suthar
,
Robert Kauffman
Keywords(s):
Antibody
,
COVID19
,
Microbiology/Infectious Diseases
Category(s):
TechPub Algolia > Diagnostics
,
TechPub Algolia > Therapeutics
Promising Antibodies Target Virus Glycoprotein for Vaccination and Therapy
ApplicationAntibodies that bind and neutralize Ebola virus glycoprotein (GP) for use in vaccination or treatment of Ebola virus disease.Key BenefitsHigher binding affinity for Ebola virus GP than closest competitor.Can be used prophylactically or for treatment of Ebola virus disease.Market SummaryThe Ebola virus is an RNA virus with a membrane composed...
Published: 8/22/2024
|
Inventor(s):
Rafi Ahmed
,
Carl Davis
,
Erica Ollmann Saphire
Keywords(s):
Antibody
,
Microbiology/Infectious Diseases
Category(s):
TechPub Algolia > Therapeutics
,
TechPub Algolia > Vaccines